
À propos de ce podcast
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
396 épisodes · Levenswetenschappen
BioCentury This Week
À propos de ce podcast
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Épisodes récents
- Ep. 390 - Live from Amsterdam: Grand Rounds Europe takeaways30 sept. · 34 min
- Ep. 389 - IgA nephropathy, Overton hearing, reverse mergers' new look29 sept. · 37 min
- Ep. 388 - Biotech IPOs, CAR T safety & pharma tariffs22 sept. · 32 min
- Ep. 387 - Psychedelics at FDA, Mike Davis’ CDER & tRNAs15 sept. · 31 min
- Ep. 386 - Novartis misses, pharma deals analysis, MFN carve-outs9 sept. · 35 min
- Ep. 385 - MFN deals, Lilly takeout, FDA pick Overton1 sept. · 36 min
- Ep. 384 - Back to School Special: The global FIH trials race28 août · 43 min
- Ep. 383 - Moderna, Genentech obesity deal, Trump's FDA pick25 août · 19 min
- Ep. 382 - Summer’s venture wave; drugging beta-catenin; Capricor & FDA18 août · 25 min
- Ep. 381 - FIH urgency in the U.S. Plus: federated learning, biotech IPOs11 août · 32 min